Cholesteryl ester storage disease: Protean presentations of lysosomal acid lipase deficiency

Journal of Pediatric Gastroenterology and Nutrition

Volumn 56, Issue 6, 2013, Pages 682-685

  Zhang, Bingnan ^a   Porto, Anthony F ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cholesteryl ester storage disease; LIPA gene; lysosomal acid lipase deficiency; nonalcoholic fatty liver disease; Wolman disease

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ABDOMINAL PAIN; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROSIS; CHOLESTEROL ESTER STORAGE DISEASE; DIARRHEA; FAILURE TO THRIVE; GALLBLADDER DISEASE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEPATOMEGALY; HUMAN; INCIDENCE; KIDNEY CALCIFICATION; LIPID STORAGE; LIVER FIBROSIS; PHENOTYPE; PRIORITY JOURNAL; SPLENOMEGALY; SYSTEMATIC REVIEW; VOMITING; WOLMAN DISEASE;

ANIMALS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL ESTER STORAGE DISEASE; DIAGNOSIS, DIFFERENTIAL; FATTY LIVER; HUMANS; MUTATION; STEROL ESTERASE; WOLMAN DISEASE;

PROTEA;

EID: 84878946137     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31828b36ac     Document Type: Article

References (25)

1. Wolman M, Sterk VV, Gatt S, et al. Primary familial xanthomatosis with involvement and calcification of the adrenals. Pediatrics 1961;28:742.
2. Abramov A, Schorr S, Wolman M. Generalized xanthomatosis with calcified adrenals. Am J Dis Child 1956;91:282.
3. Fredrickson DS. Newly recognized disorders of cholesterol metabolism. Ann Intern Med 1963;58:718.
4. Beaudet AL, Ferry GD, Nichols BL Jr et al. Cholesterol ester storage disease: clinical, biochemical, and pathological studies. J Pediatr 1997; 90:910-4.
5. Tarantino MD, McNamara DJ, Granstrom P, et al. Lovastatin therapy for cholesterol ester storage disease in two sisters. J Pediatr 1991; 118:131-5.
6. Di Bisceglie AM, Ishak KG, Rabin L, et al. Cholesteryl ester storage disease: hepatopathology and effects of therapy with lovastatin. Hepatology 1990;11:764-72.
7. Du H, Sheriff S, Bezerra J, et al. Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease. Mol Genet Metab 1998;64:126-34.
8. Pagani F, Pariyarath R, Garcia R, et al. New lysosomal acid lipase gene mutants explain the phenotype of Wolman disease and cholesteryl ester storage disease. J Lipid Res 1998;39:1382-8.
9. Elleder M, Ledvinová J, Cieslar P. Subclinical course of cholesterol ester storage disease (CESD) diagnosed in adulthood. Report on two cases with remarks on the nature of the liver storage process. Virchows Arch A Pathol Anat Histopathol 1990;416:357-65.
10. Cummings MH, Watts GE. Increased hepatic secretion of very-lowdensity lipoprotein apolipoprotein B-100 in cholesteryl ester storage disease. Clin Chem 1995;41:1114.
11. Klima H, Ullrich K, Aslanidis C, et al. A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease. J Clin Invest 1993;92:2713-8.
12. Muntoni S, Wiebusch H, Funke H, et al. Homozygosity for a splice junction mutation in exon 8 of the gene encoding lysosomal acid lipase in a Spanish kindred with cholesterol ester storage disease (CESD). Hum Genet 1995;95:491-4.
13. Muntoni S,Wiebusch H, Jansen-Rust M, et al. Prevalence of cholesteryl ester storage disease. Arterioscler Thromb Vasc Biol 2007;27:1866-8.
14. Grabowski GA, Charnas L, Du H. Lysosomal acid lipase deficiencies: the Wolman disease/cholesterol ester storage disease spectrum. The Online Metabolic & Molecular Bases of Inherited Disease. http://www.ommbid.com/OMMBID/a/c. html/lysosomal-disorders/acid-lipase-deficiency-wolman-disease-cholesteryl- ester-storage-disease. Accessed February 16, 2013.
15. Anderson RA, Bryson GM, Parks JS. Lysosomal acid lipase mutations that determine phenotype in Wolman and cholesterol ester storage disease. Mol Genet Metab 1999;68:333-45.
16. Tylki-Szyman'ska A, Rujner J, Lugowska A, et al. Clinical, biochemical and histological analysis of seven patients with cholesteryl ester storage disease. Acta Paediatr Jpn 1997;39:643-6.
17. Lysosomal Acid Lipase Analysis. Baylor College of Medicine, Medical Genetics Laboratories. https://www.bcm.edu/geneticlabs/test-detail.cfm? testcode=4504&show=1. Accessed November 26, 2012.
18. Pisciotta L, Fresa R, Bellocchio A, et al. Cholesteryl ester storage disease (CESD) due to novel mutations in the LIPA gene. Mol Genet Metab 2009;97:143-8.
19. Vom Dahl S, Harzer K, Rolfs A, et al. Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase-1 exon 8 splice junction mutation. J Hepatol 1999;31:741-6.
20. Kleinman RE, Goulet OJ, et al. Lysosomal acid lipase deficiencies: Wolman disease and cholesteryl ester storage disease. In: Walker's Pediatric Gastrointestinal Disease. Toronto: BC Decker Inc; 2008:1025.
21. Chatrath H, Steven K, Attar B. Cholesterol ester storage disease (CESD) diagnosed in an asymptomatic adult. Dig Dis Sci 2009; 54:168-73.
22. Tadiboyina VT, Liu DM, Miskie BA, et al. Treatment of dyslipidemia with lovastatin and ezetimibe in an adolescent with cholesterol ester storage disease. Lipids Health Dis 2005; 4:26.
23. Pagani F, Garcia R, Pariyarath R, et al. Expression of lysosomal acid lipase mutatnts detected in three patients with cholesteryl ester storage disease. Hum Mol Genet 1996;5:1611-7.
24. Ferry GD, Whisennand HH, Finegold MJ, et al. Liver transplantation for cholesteryl ester storage disease. J Pediatr Gastroenterol Nutr 1991; 12:376-8.
25. Synageva Lysosomal Acid Lipase Deficiency Program. http://www. synageva.com/programs-clinical-development-sebelipase-alfa.htm. Accessed November 26, 2012.